- 作者:Véronique Lefebvre ; Pallavi Bhattaram
- 关键词:Bone ; Cartilage ; Cell fate ; Progenitor/stem cell ; SOXC ; Transcription
- 刊名:Current Osteoporosis Reports
- 出版年:2016
- 出版时间:February 2016
- 年:2016
- 卷:14
- 期:1
- 页码:32-38
- 全文大小:292 KB
- 参考文献:1.Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276–87.CrossRef PubMed PubMedCentral
2.Binkley N, Adler R, Bilezikian JP. Osteoporosis diagnosis in men: the T-score controversy revisited. Curr Osteoporos Rep. 2014;12(4):403–9.CrossRef PubMed PubMedCentral
3.Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal osteoporosis: the Women’s Health Initiative. Semin Reprod Med. 2014;32(6):454–62.CrossRef PubMed
4.Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature. 1991;351(6322):117–21.CrossRef PubMed
5.Schepers GE, Teasdale RD, Koopman P. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell. 2002;3(2):167–70.CrossRef PubMed
6.Lefebvre V, Dumitriu B, Penzo-Méndez A, Han Y, Pallavi B. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol. 2007;39(12):2195–214.CrossRef PubMed PubMedCentral
7.Kamachi Y, Kondoh H. Sox proteins: regulators of cell fate specification and differentiation. Development. 2013;140(20):4129–44.CrossRef PubMed
8.Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 2013;12(1):15–30.CrossRef PubMed PubMedCentral
9.Phochanukul N, Russell S. No backbone but lots of Sox: invertebrate Sox genes. Int J Biochem Cell Biol. 2010;42(3):453–64.CrossRef PubMed
10.Dy P, Penzo-Méndez A, Wang H, Pedraza CE, Macklin WB, Lefebvre V. The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res. 2008;36(9):3101–17.CrossRef PubMed PubMedCentral
11.van Beest M, Dooijes D, van De Wetering M, Kjaerulff S, Bonvin A, Nielsen O, et al. Sequence-specific high mobility group box factors recognize 10-12-base pair minor groove motifs. J Biol Chem. 2000;275(35):27266–73.PubMed
12.Hoser M, Potzner MR, Koch JM, Bösl MR, Wegner M, Sock E. Sox12 deletion in the mouse reveals nonreciprocal redundancy with the related Sox4 and Sox11 transcription factors. Mol Cell Biol. 2008;28(15):4675–87.CrossRef PubMed PubMedCentral
13.Mallampati S, Sun B, Lu Y, Ma H, Gong Y, Wang D, et al. Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1epsilon. Blood. 2014;123(26):4064–76.CrossRef PubMed PubMedCentral
14.Kuo PY, Leshchenko VV, Fazzari MJ, Perumal D, Gellen T, He T, et al. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene. 2015;34(10):1231–40.CrossRef PubMed PubMedCentral
15.van de Wetering M, Oosterwegel M, van Norren K, Clevers H. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 1993;12(10):3847–54.PubMed PubMedCentral
16.Lioubinski O, Müller M, Wegner M, Sander M. Expression of Sox transcription factors in the developing mouse pancreas. Dev Dyn. 2003;227(3):402–8.CrossRef PubMed
17.Sun B, Mallampati S, Gong Y, Wang D, Lefebvre V, Sun X. Sox4 is required for the survival of pro-B cells. J Immunol. 2013;190(5):2080–9.CrossRef PubMed PubMedCentral
18.Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PA, van de Wetering M, et al. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature. 1996;380(6576):711–4.CrossRef PubMed
19.Sock E, Rettig SD, Enderich J, Bösl MR, Tamm ER, Wegner M. Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol Cell Biol. 2004;24(15):6635–44.CrossRef PubMed PubMedCentral
20.Bhattaram P, Penzo-Méndez A, Sock E, Colmenares C, Kaneko KJ, Vassilev A, et al. Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors. Nat Commun. 2010;1:9.CrossRef PubMed
21.Thein DC, Thalhammer JM, Hartwig AC, Crenshaw 3rd EB, Lefebvre V, Wegner M, et al. The closely related transcription factors Sox4 and Sox11 function as survival factors during spinal cord development. J Neurochem. 2010;115(1):131–41.CrossRef PubMed PubMedCentral
22.Potzner MR, Tsarovina K, Binder E, Penzo-Méndez A, Lefebvre V, Rohrer H, et al. Sequential requirement of Sox4 and Sox11 during development of the sympathetic nervous system. Development. 2010;137(5):775–84.CrossRef PubMed PubMedCentral
23.Lin L, Lee VM, Wang Y, Lin JS, Sock E, Wegner M, et al. Sox11 regulates survival and axonal growth of embryonic sensory neurons. Dev Dyn. 2011;240(1):52–64.CrossRef PubMed
24.Jiang Y, Ding Q, Xie X, Libby RT, Lefebvre V, Gan L. Transcription factors SOX4 and SOX11 function redundantly to regulate the development of mouse retinal ganglion cells. J Biol Chem. 2013;288(25):18429–38.CrossRef PubMed PubMedCentral
25.Paul MH, Harvey RP, Wegner M, Sock E. Cardiac outflow tract development relies on the complex function of Sox4 and Sox11 in multiple cell types. Cell Mol Life Sci. 2014;71(15):2931–45.CrossRef PubMed
26.Bergsland M, Werme M, Malewicz M, Perlmann T, Muhr J. The establishment of neuronal properties is controlled by Sox4 and Sox11. Genes Dev. 2006;20(24):3475–86.CrossRef PubMed PubMedCentral
27.Bergsland M, Ramsköld D, Zaouter C, Klum S, Sandberg R, Muhr J. Sequentially acting Sox transcription factors in neural lineage development. Genes Dev. 2011;25(23):2453–64.CrossRef PubMed PubMedCentral
28.Schilham MW, Moerer P, Cumano A, Clevers HC. Sox-4 facilitates thymocyte differentiation. Eur J Immunol. 1997;27(5):1292–5.CrossRef PubMed
29.Mu L, Berti L, Masserdotti G, Covic M, Michaelidis TM, Doberauer K, et al. SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis. J Neurosci. 2012;32(9):3067–80.CrossRef PubMed PubMedCentral
30.Penzo-Méndez AI. Critical roles for SoxC transcription factors in development and cancer. Int J Biochem Cell Biol. 2010;42(3):425–8.CrossRef PubMed PubMedCentral
31.Jafarnejad SM, Ardekani GS, Ghaffari M, Li G. Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis. Cell Mol Life Sci. 2013;70(15):2677–96.CrossRef PubMed
32.Lu TX, Li JY, Xu W. The role of SOX11 in mantle cell lymphoma. Leuk Res. 2013;37(11):1412–9.CrossRef PubMed
33.•
Vervoort SJ, van Boxtel R, Coffer PJ. The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene. 2013;32(29):3397–409. This paper reviews current knowledge on SOXC proteins in various types of cancer.CrossRef PubMed
34.Song GD, Sun Y, Shen H, Li W. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients. Tumour Biol. 2015;36(6):4167–73.CrossRef PubMed
35.Ramezani-Rad P, Geng H, Hurtz C, Chan LN, Chen Z, Jumaa H, et al. SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood. 2013;121(1):148–55.CrossRef PubMed PubMedCentral
36.Brennan DJ, Ek S, Doyle E, Drew T, Foley M, Flannelly G, et al. The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer. 2009;45(8):1510–7.CrossRef PubMed
37.Hide T, Takezaki T, Nakatani Y, Nakamura H, Kuratsu J, Kondo T. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation. Cancer Res. 2009;69(20):7953–9.CrossRef PubMed
38.Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23(6):768–83.CrossRef PubMed
39.Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou T, et al. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci U S A. 2009;106(10):3788–93.CrossRef PubMed PubMedCentral
40.Moreno CS. The sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. Am J Pathol. 2010;176(2):518–27.CrossRef PubMed PubMedCentral
41.Zhang J, Jiang H, Shao J, Mao R, Liu J, Ma Y, et al. SOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axis. BMC Neurol. 2014;14:207.CrossRef PubMed PubMedCentral
42.Lefebvre V, Bhattaram P. Vertebrate skeletogenesis. Curr Top Dev Biol. 2010;90:291–317.CrossRef PubMed PubMedCentral
43.Long F, Ornitz DM. Development of the endochondral skeleton. Cold Spring Harb Perspect Biol. 2013;5(1):a008334.CrossRef PubMed PubMedCentral
44.•
Kozhemyakina E, Lassar AB, Zelzer E. A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development. 2015;142(5):817–31. This paper provides a comprehensive overview of current knowledge of molecular mechanisms controlling skeletogenesis.CrossRef PubMed PubMedCentral
45.Cameron TL, Belluoccio D, Farlie PG, Brachvogel B, Bateman JF. Global comparative transcriptome analysis of cartilage formation in vivo. BMC Dev Biol. 2009;9:20.CrossRef PubMed PubMedCentral
46.Kan A, Ikeda T, Fukai A, Nakagawa T, Nakamura K, Chung UI, et al. SOX11 contributes to the regulation of GDF5 in joint maintenance. BMC Dev Biol. 2013;13:4.CrossRef PubMed PubMedCentral